IHM
RCKT icon

Iguana Healthcare Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Iguana Healthcare Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$2.34M Buy
+125,000
New +$2.04M 1.54% 28

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Iguana Healthcare Management's RCKT Position: Q1 2018 in Review

Iguana Healthcare Management opened a new position in Rocket Pharmaceuticals (RCKT) in Q1 2018: 125,000 shares worth $2.34M. The stake represents 1.54% of the portfolio and ranks #28 among its holdings.

56 funds tracked by Wall St. Rank hold RCKT as of Q1 2018.

  • Iguana Healthcare Management held 125,000 shares of Rocket Pharmaceuticals worth $2.34M as of Q1 2018.
  • Rocket Pharmaceuticals was a new Iguana Healthcare Management position in Q1 2018.
  • Rocket Pharmaceuticals made up 1.54% of Iguana Healthcare Management's portfolio in Q1 2018, its #28 holding.
  • 56 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.